Encysive Pharmaceuticals

Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.

Business Model:

Revenue: $0

Employees: 51-500

Rankings

Detailed Encysive Pharmaceuticals Information

Encysive Pharmaceuticals was acquired by Pfizer.
The acquisition happend on 2008-02-20.
Details of the transaction were not public

Acquirer

Geographic Data

Encysive Pharmaceuticals headquarters map

Address:

City: Houston

State: Texas

Zip:

Country: United States

Financial Info

Stage:

private equity

Raised Last:

$14M

Raised Total:

$89M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Encysive Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes synthetic and small molecule compounds to address medical needs worldwide. The company focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade, and vascular diseases. Its products include Argatroban for the treatment of heparin-induced thrombocytopenia; and Thelin (sitaxsentan sodium), an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, congestive heart failure, and essential hypertension. The company&s;s clinical development compounds include TBC3711, an endothelin receptor antagonist; TBC4746, an antigen-4 antagonist; ENC8003, a G protein-coupled receptor; and bimosiamose, a selectin antagonist. Encysive Pharmaceuticals has research collaboration and license agreements with GlaxoSmithKline plc; Mitsubishi Pharma Corporation; Schering-Plough, Ltd.; Schering Corporation; and Revotar Biopharmaceuticals, AG. The company was founded in 1989. It was formerly known as Texas Biotechnology Corporation and changed its name to Encysive Pharmaceuticals, Inc. in 2003. Encysive Pharmaceuticals is based in Houston, Texas. As of June 10, 2008, Encysive Pharmaceuticals Inc. operates as a subsidiary of Pfizer Inc.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2007 Private Equity Round $0 Enable Capital Management
Hudson Capital Group
Enable Capital Management
Hudson Capital Group
10/2006 Private Equity Round 1 $75M Azimuth Opportunity
Azimuth Opportunity
8/2007 Private Equity Round 2 $13.9M Enable Capital Management
Hudson Capital Group
Enable Capital Management
Hudson Capital Group
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research